Microneedle Drug Delivery CRO/CDMO
Hours: 8:30 AM–5:30 PMSales: +86 10 8928 7035Business: bd@casmn.com

MICRONEEDLE DEVELOPMENT CAPABILITY

Microneedle Formulation Development

Develop a formulation that balances payload stability, microneedle performance, delivery requirements and manufacturing feasibility.

Connecting Payload Placement with Microneedle Structure

Illustrative structure. Formulation and architecture are selected according to project-specific requirements.
01

Why Formulation Design Matters

Formulation design balances payload stability, loading, microneedle performance, delivery requirements and manufacturing feasibility.

02

Payload–Material Compatibility

Payload properties, water sensitivity, processing conditions and matrix interactions are evaluated together before a candidate formulation is selected.

03

Polymer and Excipient Selection

Polymer grade, molecular weight, excipient selection and residual moisture are considered against mechanical, dissolution and stability requirements.

04

Drug Loading Strategy

Loading can be homogeneous, tip-focused, layered or another project-specific architecture. These are options, not a default structure for all formulations.

05

Mechanical and Dissolution Requirements

Geometry, matrix composition and product use requirements guide evaluation of insertion performance, structural integrity and dissolution behavior.

06

Prototype Selection and Outputs

Candidate formulations and prototypes are selected from agreed data, with the next development scope defined from the outcome.

Technical Review — Reviewed by: CASMN R&D Team · Last reviewed: August 2026.

Discuss This Capability

Send your target product, payload, development stage and cooperation scope to our business development team.

Start a Project